The current study found that CD24 gene expression was considerably greater in NAFLD cases compared to controls, and the normalized CD24 gene expression in NAFLD was up-regulated 6.56-fold. This evidence concerns the gene CD24 and metabolic dysfunction-associated steatotic liver disease.